By Elliot Weld ( August 8, 2025, 8:13 PM EDT) -- British pharmaceutical company GlaxoSmithKline said Friday it stands to make up to $500 million from settlements between German biotech companies CureVac and BioNTech after their legal disputes were squashed by a merger....

See Full Page